Most Recent
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.
A trade mark application by a China Australia trade association contains an "identical copy" of the Sydney Opera House's sail design, the trust behind the iconic landmark has claimed as it seeks revocation of the mark on the grounds of bad faith.
Swiss drug giant Novartis has secured an injunction temporarily blocking drug maker Pharmacor from launching a generic version of the company’s top-selling MS drug Gilenya in Australia.
Two patent attorneys being sued by boutique IP firm Pizzeys Patent and Trade Mark Attorneys have hit back against claims they misused confidential information to poach clients, arguing the terms of the non-compete restraint in their employment contracts were "unclear", "unreasonable" and "unenforceable".
Two patent attorneys who resigned from Pizzeys Patent and Trade Mark Attorneys to launch a competing business performed work for clients of the boutique IP firm a year after they jumped ship, in breach of their employment contracts, a lawsuit claims.
The Sydney Opera House is challenging a ruling that denied its opposition to a trade mark application filed by a China-Australia trade association that featured an image of the opera house sails together with the Great Wall of China.
The High Court has declined to take up Mylan's challenge to a Full Court ruling upholding the invalidity of three patents for its blockbuster cholesterol drug Lipidil.
Sydney-based research foundation Brien Holden Vision Institute has filed a lawsuit alleging three senior researchers misused confidential information when they jumped ship to a rival research group and filed applications to patent seven inventions for opthalmic lenses designed to treat myopia allegedly based on that information.
The Federal Court has granted a bid by global solar cell manufacturer Hanwha to amend the patent behind its solar technology at the centre of a hotly contested infringement case against three rivals.
Consumer goods giant Procter & Gamble has dropped a lawsuit accusing competitor Colgate-Palmolive of breaching consumer laws by making false claims about the performance of its whitening toothpaste that threatened to push its own brand of whitener off the shelves.